# Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-malaria-antibody-infants-lowers-immune.html) · 2026-11-20 · Medicine
Page: https://themorning.science/story/malaria-antibody-protects-infants-but-lowers-immune-response-to-r21-vaccine-tria-78cde72e248d4a21
Kind: research · Impact: medium

## In brief

- A single intramuscular dose of the experimental malaria monoclonal antibody L9LS safely gave infants strong protection during Mali's six-month malaria season.
- The antibody may interfere with the immune response to the R21 malaria vaccine.
- This potential interference puts plans to pursue development of L9LS in question.

## Why it matters

Monoclonal antibodies could offer a complementary tool against malaria in infants, but if they blunt vaccine responses, combined immunization strategies would need to be reconsidered.

## Timeline

- 2026-11-20: Trial results reported showing infant protection and possible interference with R21 vaccine response

## Coverage

- [Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds](https://medicalxpress.com/news/2026-11-malaria-antibody-infants-lowers-immune.html) — Medical Xpress - latest medical and health news stories, 2026-11-20

Tags: malaria, monoclonal antibody, vaccines, infants, clinical trial

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
